Laboratory revenue cycle management encompasses every operational process connecting clinical laboratory services to collected Medicare reimbursement – and in August 2026, it has become the most actionable lever available to laboratory executives preparing for a confirmed payment shift. The Consolidated Appropriations Act, 2026, signed February 3, 2026, delayed all PAMA-related Clinical Laboratory Fee Schedule (CLFS) rate reductions through December 31, 2026 – the seventh Congressional intervention since PAMA was enacted [1]. But the reprieve is temporary.

In 2026, orthopedic revenue leakage is becoming a growing financial concern for healthcare organizations across the Unit...
read more
Orthopedic billing services are the specialized revenue cycle functions that manage claim submission, coding accuracy, p...
read more
The CMS Transforming Episode Accountability Model (TEAM) is in play, and its impact on orthopedic billing services will ...
read more
The healthcare revenue cycle has recently seen a flurry of coding solutions from some of the most recognized names in AI...
read more
You’re wrapping up a 10-hour shift. One more note to finish, one last patient to call – and then someone from billing wa...
read more
The medical billing outsourcing market is experiencing unprecedented growth, with the global market size projected to re...
read more
Let’s face it: medical billing isn’t exactly the most glamorous part of running a healthcare practice. But it is the par...
read more
For revenue cycle leaders, maintaining compliance while minimizing financial risk is an ongoing challenge. As healthcare...
read more
In the high-stakes world of healthcare finance, where razor-thin margins and rising regulatory scrutiny are the norm, me...
read more